Breaking News Instant updates and real-time market news.

KPTI

Karyopharm

$19.12 /

+1.3 (+7.30%)

07:15
04/07/20
04/07
07:15
04/07/20
07:15

Karyopharm to evaluate low dose selinexor as potential treatment for COVID-19

Karyopharm Therapeutics announced plans to initiate a global randomized clinical trial for low dose oral selinexor in hospitalized patients with severe COVID-19. Selinexor, marketed as XPOVIO, is currently approved at higher doses by the Food and Drug Administration as a treatment for patients with relapsed or refractory multiple myeloma. Selinexor is an oral, selective inhibitor of nuclear export compound which blocks the cellular protein XPO1. In addition to its roles in cancer, XPO1 also facilitates the transport of several viral proteins from the nucleus of the host cell to the cytoplasm1, and it amplifies the activities of pro-inflammatory transcription factors. SINE compounds have been shown to disrupt the replication of multiple viruses in vitro and in vivo. They have also been shown to mediate anti-inflammatory and anti-viral effects, including respiratory infections, in several animal models. In particular, SINE compounds have recently been identified as having the potential to interfere with key host protein interactions with SARS-CoV-2, the virus that causes COVID-19.2 Selinexor is currently the only XPO1 inhibitor approved for commercial use by the FDA and has been extensively tested in clinical trials across numerous cancer indications worldwide since 2012. The proposed clinical trial to treat hospitalized patients with COVID-19 would be the first study of an XPO1 inhibitor in patients with severe viral infections. SINE XPO1 inhibitors have demonstrated activity against over 20 different viruses, including the RNA viruses, influenza, respiratory syncytial virus and other common causes of respiratory infection. XPO1 inhibition has been identified in several assays as having potential activity against SARS-CoV-2, although specific animal models have not been available to date. One of the most important aspects of COVID-19 is the marked pulmonary inflammation with high levels of cytokines such as IL6, IL1, IFNg and others. Along these lines, selinexor and other SINE compounds have demonstrated potent anti-inflammatory activity through the inhibition of Nuclear Factor kB, leading to reductions in all of these cytokines in a variety of models, and this may be particularly beneficial to hospitalized patients with COVID-19. Karyopharm's clinical program in COVID-19 is not expected to impact the timing or prioritization of other key Company milestones, including the planned submission of a sNDA for XPOVIO in combination with once-weekly Velcade and low-dose dexamethasone as a new second line treatment for patients with relapsed or refractory multiple myeloma, which remains on schedule for the second quarter of 2020. Additionally, Karyopharm has sufficient supply of selinexor for current and expected commercial supply for patients with multiple myeloma, for ongoing clinical trials in patients with various cancers, as well as for this proposed study in patients with COVID-19.

  • 23

    Jun

KPTI Karyopharm
$19.12 /

+1.3 (+7.30%)

03/04/20 Barclays
Karyopharm initiated with an Overweight at Barclays
03/03/20 Canaccord
Karyopharm price target raised to $35 from $22 at Canaccord
03/02/20 Wedbush
Karyopharm price target raised to $25 from $19 at Wedbush
03/02/20 H.C. Wainwright
Karyopharm price target raised to $43 from $40 at H.C. Wainwright

TODAY'S FREE FLY STORIES

Upgrade
Boliden upgraded to Buy from Neutral at BofA » 05:35
05/29/20
05/29
05:35
05/29/20
05:35
BDNNY

Boliden

$0.00 /

+ (+0.00%)

BofA upgraded Boliden to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BDNNY Boliden
$0.00 /

+ (+0.00%)

05/07/20 Credit Suisse
Boliden upgraded to Outperform from Neutral at Credit Suisse
05/07/20 Credit Suisse
Boliden upgraded to Outperform from Neutral at Credit Suisse
04/30/20 JPMorgan
Boliden price target lowered to SEK 250 from SEK 260 at JPMorgan
04/30/20 Citi
Boliden downgraded to Neutral from Buy at Citi
Downgrade
Saint-Gobain downgraded to Hold from Buy at DZ Bank » 05:33
05/29/20
05/29
05:33
05/29/20
05:33
CODYY

Saint-Gobain

$0.00 /

+ (+0.00%)

DZ Bank analyst Matthias…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CODYY Saint-Gobain
$0.00 /

+ (+0.00%)

03/31/20 Jefferies
Saint-Gobain upgraded to Hold from Underperform at Jefferies
11/13/19 Jefferies
Continental Building buyout modest negative for Eagle Materials, says Jefferies
07/17/19 Goldman Sachs
Saint-Gobain initiated with a Buy at Goldman Sachs
Upgrade
Flutter Entertainment upgraded to Hold from Reduce at Peel Hunt » 05:33
05/29/20
05/29
05:33
05/29/20
05:33
PDYPY

Flutter Entertainment

$0.00 /

+ (+0.00%)

Peel Hunt analyst Ivor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PDYPY Flutter Entertainment
$0.00 /

+ (+0.00%)

05/28/20 Jefferies
Flutter Entertainment share sale a 'confident, proactive step,' says Jefferies
05/19/20 Morgan Stanley
Flutter price target raised to 10,400 GBp from 8,500 GBp at Morgan Stanley
05/07/20 AlphaValue
Flutter Entertainment upgraded to Add from Sell at AlphaValue
05/06/20 Deutsche Bank
Flutter Entertainment price target raised to 9,000 GBp at Deutsche Bank
PDYPY Flutter Entertainment
$0.00 /

+ (+0.00%)

Initiation
Biffa initiated with a Buy at Investec » 05:32
05/29/20
05/29
05:32
05/29/20
05:32
BFFBF

Biffa

$0.00 /

+ (+0.00%)

Investec initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
OMA upgraded to Outperform from Neutral at Credit Suisse » 05:31
05/29/20
05/29
05:31
05/29/20
05:31
OMAB

OMA

$34.95 /

-1.29 (-3.56%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OMAB OMA
$34.95 /

-1.29 (-3.56%)

OMAB OMA
$34.95 /

-1.29 (-3.56%)

04/08/20 Goldman Sachs
OMA upgraded to Buy from Neutral at Goldman Sachs
04/08/20 UBS
GAP Airports upgraded to Buy from Neutral at UBS
03/31/20 Barclays
Barclays double upgrades OMA, downgrades GAP Airports
03/31/20 Barclays
OMA upgraded to Overweight from Underweight at Barclays
OMAB OMA
$34.95 /

-1.29 (-3.56%)

Upgrade
Bloomin' Brands upgraded to Buy from Hold at Jefferies » 05:30
05/29/20
05/29
05:30
05/29/20
05:30
BLMN

Bloomin' Brands

$11.39 /

-0.73 (-6.02%)

Jefferies analyst Andy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BLMN Bloomin' Brands
$11.39 /

-0.73 (-6.02%)

BLMN Bloomin' Brands
$11.39 /

-0.73 (-6.02%)

05/13/20 Loop Capital
Bloomin' Brands price target lowered to $15 from $27 at Loop Capital
05/11/20 Guggenheim
Bloomin' Brands price target raised to $15 from $11 at Guggenheim
05/05/20 Wells Fargo
Bloomin' Brands price target lowered to $11 from $23 at Wells Fargo
04/17/20 Deutsche Bank
Bloomin' Brands price target lowered to $14 from $23 at Deutsche Bank
BLMN Bloomin' Brands
$11.39 /

-0.73 (-6.02%)

BLMN Bloomin' Brands
$11.39 /

-0.73 (-6.02%)

Hot Stocks
Chi-Med announces NDA acceptance in China for savolitinib » 05:29
05/29/20
05/29
05:29
05/29/20
05:29
HCM

Hutchison China MediTech

$21.24 /

+1.3 (+6.52%)

Hutchison China MediTech…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HCM Hutchison China MediTech
$21.24 /

+1.3 (+6.52%)

HCM Hutchison China MediTech
$21.24 /

+1.3 (+6.52%)

03/13/20
Fly Intel: Top analyst initiations
03/12/20 Cantor Fitzgerald
Hutchison China MediTech initiated with an Overweight at Cantor Fitzgerald
02/20/20
Fly Intel: Top five analyst initiations
02/20/20 Goldman Sachs
Hutchison China MediTech initiated with a Buy at Goldman Sachs
Downgrade
Hugo Boss downgraded to Hold from Buy at DZ Bank » 05:29
05/29/20
05/29
05:29
05/29/20
05:29
BOSSY

Hugo Boss

$0.00 /

+ (+0.00%)

DZ Bank analyst Herbert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BOSSY Hugo Boss
$0.00 /

+ (+0.00%)

05/07/20 HSBC
Hugo Boss price target lowered to EUR 26.50 from EUR 50 at HSBC
05/06/20 Deutsche Bank
Hugo Boss price target lowered to EUR 31 from EUR 35 at Deutsche Bank
05/06/20 JPMorgan
Hugo Boss price target lowered to EUR 41 from EUR 45 at JPMorgan
03/30/20 Citi
Hugo Boss price target lowered to EUR 27 from EUR 41 at Citi
Upgrade
BHP Group upgraded to Buy from Neutral at BofA » 05:28
05/29/20
05/29
05:28
05/29/20
05:28
BHP

BHP Group

$46.70 /

+0.49 (+1.06%)

BofA analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BHP BHP Group
$46.70 /

+0.49 (+1.06%)

BHP BHP Group
$46.70 /

+0.49 (+1.06%)

05/13/20 UBS
BHP Group upgraded to Buy on valuation after pullback at UBS
05/13/20 UBS
BHP Group upgraded to Buy from Neutral at UBS
05/11/20 JPMorgan
BHP Group price target lowered to 1,780 GBp from 1,830 GBp at JPMorgan
04/30/20 JPMorgan
BHP Group price target raised to 1,830 GBp from 1,820 GBp at JPMorgan
BHP BHP Group
$46.70 /

+0.49 (+1.06%)

BHP BHP Group
$46.70 /

+0.49 (+1.06%)

Upgrade
Rio Tinto upgraded to Buy from Neutral at BofA » 05:28
05/29/20
05/29
05:28
05/29/20
05:28
RIO

Rio Tinto

$52.52 /

+0.18 (+0.34%)

BofA analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RIO Rio Tinto
$52.52 /

+0.18 (+0.34%)

RIO Rio Tinto
$52.52 /

+0.18 (+0.34%)

05/26/20 Morgan Stanley
Rio Tinto price target lowered to 4,300 GBp from 4,400 GBp at Morgan Stanley
05/22/20 Jefferies
Jefferies adds six names to Franchise Picks list, including BioMarin and TJX
05/20/20 UBS
Rio Tinto price target lowered to 4,100 GBp from 4,250 GBp at UBS
05/18/20 Jefferies
Jefferies names Beazley, Ferguson, Novartis, Rio Tinto high conviction ideas
RIO Rio Tinto
$52.52 /

+0.18 (+0.34%)

RIO Rio Tinto
$52.52 /

+0.18 (+0.34%)

RIO Rio Tinto
$52.52 /

+0.18 (+0.34%)

Hot Stocks
Sanofi appoints new Chief People Officer, Chief Digital Officer » 05:26
05/29/20
05/29
05:26
05/29/20
05:26
SNY

Sanofi

$48.67 /

+1.16 (+2.44%)

Sanofi said in a release,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$48.67 /

+1.16 (+2.44%)

SNY Sanofi
$48.67 /

+1.16 (+2.44%)

05/28/20 Piper Sandler
Alexion settlement could 'clear the deck' for acquirer, says Piper Sandler
05/27/20 Citi
BioMarin a good takeout candidate, but not by Sanofi, says Citi
05/26/20 UBS
Sanofi price target lowered to EUR 101 from EUR 103 at UBS
05/26/20 Piper Sandler
Piper remains buyer of Regeneron, ups target to $630 on buyback accretion
SNY Sanofi
$48.67 /

+1.16 (+2.44%)

SNY Sanofi
$48.67 /

+1.16 (+2.44%)

SNY Sanofi
$48.67 /

+1.16 (+2.44%)

SNY Sanofi
$48.67 /

+1.16 (+2.44%)

Upgrade
Groupe Bruxelles Lambert upgraded to Buy from Hold at ING Bank » 05:25
05/29/20
05/29
05:25
05/29/20
05:25
GBLBY

Groupe Bruxelles Lambert

$0.00 /

+ (+0.00%)

ING Bank analyst Hans…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
Fugro downgraded to Hold from Buy at ING Bank » 05:24
05/29/20
05/29
05:24
05/29/20
05:24
FURGF

Fugro

$0.00 /

+ (+0.00%)

ING Bank analyst Quirijn…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Downgrade
MedMen downgraded to Sell from Neutral at Bryan Garnier » 05:23
05/29/20
05/29
05:23
05/29/20
05:23
MMNFF

MedMen

$0.00 /

+ (+0.00%)

Bryan Garnier analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MMNFF MedMen
$0.00 /

+ (+0.00%)

MMNFF MedMen
$0.00 /

+ (+0.00%)

05/28/20
MedMen downgraded to Sell from Hold at Canaccord
05/28/20 Canaccord
MedMen downgraded to Sell from Hold at Canaccord
02/14/20 Cantor Fitzgerald
Cantor initiates 10 cannabis names, sees opportunity after sellofff
02/13/20 Cantor Fitzgerald
MedMen initiated with a Neutral at Cantor Fitzgerald
MMNFF MedMen
$0.00 /

+ (+0.00%)

MMNFF MedMen
$0.00 /

+ (+0.00%)

Upgrade
Enel upgraded to Buy from Neutral at BofA » 05:21
05/29/20
05/29
05:21
05/29/20
05:21
ENLAY

Enel

$0.00 /

+ (+0.00%)

BofA upgraded Enel to Buy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENLAY Enel
$0.00 /

+ (+0.00%)

04/07/20 UBS
Enel price target lowered to EUR 7.50 from EUR 8.25 at UBS
03/27/20 BofA
Enel downgraded to Neutral from Buy at BofA
03/23/20 Goldman Sachs
Enel upgraded to Conviction Buy from Buy at Goldman Sachs
09/27/19 Barclays
Enel initiated with an Equal Weight at Barclays
Upgrade
PPL Corp. upgraded to Buy from Neutral at Mizuho » 05:20
05/29/20
05/29
05:20
05/29/20
05:20
PPL

PPL Corp.

$27.44 /

+0.71 (+2.66%)

Mizuho analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PPL PPL Corp.
$27.44 /

+0.71 (+2.66%)

PPL PPL Corp.
$27.44 /

+0.71 (+2.66%)

05/20/20 Seaport Global
PPL Corp. initiated with a Neutral at Seaport Global
05/20/20 Seaport Global
PPL Corp. initiated with a Neutral at Seaport Global
05/08/20 Wells Fargo
PPL Corp. downgraded to Equal Weight from Overweight at Wells Fargo
04/02/20 Citi
PPL Corp. price target lowered to $25 from $36 at Citi
PPL PPL Corp.
$27.44 /

+0.71 (+2.66%)

PPL PPL Corp.
$27.44 /

+0.71 (+2.66%)

Downgrade
Neste downgraded to Neutral from Buy at UBS » 05:20
05/29/20
05/29
05:20
05/29/20
05:20
NTOIY

Neste

$0.00 /

+ (+0.00%)

UBS analyst Henri…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTOIY Neste
$0.00 /

+ (+0.00%)

04/21/20 JPMorgan
Neste price target lowered to EUR 32 from EUR 34 at JPMorgan
04/17/20 RBC Capital
Neste price target lowered to EUR 34 from EUR 38 at RBC Capital
03/30/20 Morgan Stanley
Neste price target lowered to EUR 36.20 from EUR 42.10 at Morgan Stanley
03/23/20 UBS
Neste upgraded to Buy from Neutral at UBS
Downgrade
Elia Group downgraded to Underperform from Outperform at Exane BNP Paribas » 05:19
05/29/20
05/29
05:19
05/29/20
05:19
ELIAF

Elia Group

$0.00 /

+ (+0.00%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ELIAF Elia Group
$0.00 /

+ (+0.00%)

05/15/20 Kepler Cheuvreux
Elia Group downgraded to Hold from Buy at Kepler Cheuvreux
Upgrade
Stock Yards Bancorp upgraded to Outperform from Market Perform at Raymond James » 05:17
05/29/20
05/29
05:17
05/29/20
05:17
SYBT

Stock Yards Bancorp

$35.05 /

-0.23 (-0.65%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SYBT Stock Yards Bancorp
$35.05 /

-0.23 (-0.65%)

04/09/20 Stephens
Stephens upgrades Old National, First Busey and S.Y. Bancorp to Overweight
04/09/20 Stephens
S.Y. Bancorp upgraded to Overweight from Equal Weight at Stephens
SYBT Stock Yards Bancorp
$35.05 /

-0.23 (-0.65%)

Downgrade
Masco downgraded to Market Perform from Strong Buy at Raymond James » 05:16
05/29/20
05/29
05:16
05/29/20
05:16
MAS

Masco

$46.83 /

-0.26 (-0.55%)

Raymond James analyst Sam…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MAS Masco
$46.83 /

-0.26 (-0.55%)

MAS Masco
$46.83 /

-0.26 (-0.55%)

05/27/20 Credit Suisse
Masco initiated with an Outperform at Credit Suisse
04/30/20 Nomura Instinet
Masco price target raised to $56 from $52 at Nomura Instinet
04/14/20 Goldman Sachs
Owens Corning downgraded to Buy from Conviction Buy at Goldman Sachs
04/07/20 Loop Capital
Masco upgraded to Buy from Hold at Loop Capital
MAS Masco
$46.83 /

-0.26 (-0.55%)

MAS Masco
$46.83 /

-0.26 (-0.55%)

MAS Masco
$46.83 /

-0.26 (-0.55%)

Downgrade
DXC Technology downgraded to Neutral from Overweight at JPMorgan » 05:14
05/29/20
05/29
05:14
05/29/20
05:14
DXC

DXC Technology

$16.56 /

-1.11 (-6.28%)

JPMorgan analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DXC DXC Technology
$16.56 /

-1.11 (-6.28%)

DXC DXC Technology
$16.56 /

-1.11 (-6.28%)

03/12/20 MoffettNathanson
DXC Technology upgraded to Buy from Neutral at MoffettNathanson
03/11/20 Wells Fargo
DXC Technology price target lowered to $18 from $36 at Wells Fargo
03/11/20 Citi
DXC Technology divestiture proceeds higher than expected, says Citi
02/26/20 Morgan Stanley
DXC Technology resumed with an Overweight at Morgan Stanley
DXC DXC Technology
$16.56 /

-1.11 (-6.28%)

DXC DXC Technology
$16.56 /

-1.11 (-6.28%)

DXC DXC Technology
$16.56 /

-1.11 (-6.28%)

DXC DXC Technology
$16.56 /

-1.11 (-6.28%)

Upgrade
CNO Financial upgraded to Buy from Neutral at B. Riley FBR » 05:13
05/29/20
05/29
05:13
05/29/20
05:13
CNO

CNO Financial

$14.59 /

-0.48 (-3.19%)

B. Riley FBR analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNO CNO Financial
$14.59 /

-0.48 (-3.19%)

CNO CNO Financial
$14.59 /

-0.48 (-3.19%)

05/20/20
Fly Intel: Top five analyst initiations
05/20/20 Piper Sandler
CNO Financial initiated with a Neutral at Piper Sandler
03/11/20 B. Riley FBR
B. Riley FBR downgrades CNO Financial, Progressive to Neutral from Buy
03/11/20 B. Riley FBR
CNO Financial downgraded to Neutral from Buy at B. Riley FBR
CNO CNO Financial
$14.59 /

-0.48 (-3.19%)

Hot Stocks
Twitter says Trump 'THUGS' tweet violates glorification of violence policy » 05:11
05/29/20
05/29
05:11
05/29/20
05:11
TWTR

Twitter

$31.60 /

-1.46 (-4.42%)

Twitter said that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
$31.60 /

-1.46 (-4.42%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

05/27/20 Cowen
Cowen says Twitter 'will be fine,' but Republicans could support Facebook suit
05/06/20 China Renaissance
Twitter price target lowered to $23 from $25 at China Renaissance
05/01/20
Fly Intel: Top five analyst downgrades
05/01/20 Deutsche Bank
Twitter price target raised to $28 from $22 at Deutsche Bank
TWTR Twitter
$31.60 /

-1.46 (-4.42%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

Recommendations
Glu Mobile outlook still conservative despite uptick, says Piper Sandler » 04:59
05/29/20
05/29
04:59
05/29/20
04:59
GLUU

Glu Mobile

$8.68 /

-0.185 (-2.09%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GLUU Glu Mobile
$8.68 /

-0.185 (-2.09%)

GLUU Glu Mobile
$8.68 /

-0.185 (-2.09%)

05/11/20
Fly Intel: Top five analyst downgrades
05/11/20 Morgan Stanley
Morgan Stanley downgrades Glu Mobile after stock nearly doubled
05/10/20 Morgan Stanley
Glu Mobile downgraded to Equal Weight from Overweight at Morgan Stanley
05/08/20 Piper Sandler
Glu Mobile price target raised to $10.50 from $8 at Piper Sandler
GLUU Glu Mobile
$8.68 /

-0.185 (-2.09%)

GLUU Glu Mobile
$8.68 /

-0.185 (-2.09%)

GLUU Glu Mobile
$8.68 /

-0.185 (-2.09%)

Recommendations
VMware price target raised to $160 from $135 at Jefferies » 04:56
05/29/20
05/29
04:56
05/29/20
04:56
VMW

VMware

$142.79 /

+3.18 (+2.28%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VMW VMware
$142.79 /

+3.18 (+2.28%)

VMW VMware
$142.79 /

+3.18 (+2.28%)

05/27/20 BMO Capital
VMware price target lowered to $152 from $163 at BMO Capital
05/26/20 Morgan Stanley
Morgan Stanley sees risk to both Q1 and FY21 for VMware
05/14/20 Jefferies
VMware downgraded to Hold from Buy at Jefferies
03/24/20 Oppenheimer
VMware price target lowered to $165 from $200 at Oppenheimer
VMW VMware
$142.79 /

+3.18 (+2.28%)

VMW VMware
$142.79 /

+3.18 (+2.28%)

VMW VMware
$142.79 /

+3.18 (+2.28%)

VMW VMware
$142.79 /

+3.18 (+2.28%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.